Elin Aamdal

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma

Marta Nyakas, Elin Aamdal, Krag Jacobsen et al. · Clinical & Experimental Immunology · 2019 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

Elin Aamdal, Else Marit Inderberg, Espen B. Ellingsen et al. · Frontiers in Immunology · 2021 · 42 citations · Full text

Medicine, Immunology, Oncology +17

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Espen B. Ellingsen, Elin Aamdal, Tormod Kyrre Guren et al. · Journal for ImmunoTherapy of Cancer · 2022 · 42 citations · Full text

Medicine, Immunology, Oncology +17

Ipilimumab in a real‐world population: A prospective Phase <scp>IV</scp> trial with long‐term follow‐up

Elin Aamdal, Kari Dolven Jacobsen, Oddbjørn Straume et al. · International Journal of Cancer · 2021 · 24 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

Espen B. Ellingsen, Gergana Bounova, Iliana Kerzeli et al. · Journal of Translational Medicine · 2022 · 21 citations · Full text

Medicine, Immunology, Oncology +17